BBM — Blueberries Medical Cashflow Statement
0.000.00%
- CA$3.99m
- CA$3.94m
- CA$0.47m
Annual cashflow statement for Blueberries Medical, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -4.94 | -5.15 | -1.47 | -1.64 | -1.15 |
Depreciation | |||||
Non-Cash Items | 1.65 | 3.01 | -0.214 | 0.502 | 0.248 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 0.183 | -0.371 | -0.083 | -0.348 | -0.002 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Payable / Accrued Expenses | |||||
Change in Other Liabilities | |||||
Net Change in Other Assets & Liabilities | |||||
Cash from Operating Activities | -2.39 | -1.68 | -1.47 | -1.33 | -0.797 |
Capital Expenditures | -0.867 | -0.049 | 0 | -0.022 | 0 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 0.256 | 0 | 0.102 | 0.405 | 0.009 |
Sale of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -0.611 | -0.049 | 0.102 | 0.383 | 0.009 |
Financing Cash Flow Items | 0 | — | — | — | — |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 0.784 | 2.77 | 1.35 | 0.539 | -0.002 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -2.36 | 1.04 | 0.07 | -0.595 | -0.752 |